Basal Cell Carcinoma Around the Eyes

Basal cell carcinoma (BCC) is the most common type of skin cancer, and when it occurs on the eyelids or around the eyes, it presents unique challenges due to the delicate anatomy and potential impact on vision. This article provides a comprehensive overview of basal cell carcinoma of the eyelid, including risk factors, symptoms, diagnosis, treatment options, and important coding considerations such as ICD-10 coding for basal cell carcinoma of the left lower eyelid.

What Is Basal Cell Carcinoma of the Eyelid?

Basal cell carcinoma of the eyelid is a malignant growth that arises from the basal layer of the epidermis, typically on sun-exposed areas. The eyelids, especially the lower eyelid, are common sites because they receive significant ultraviolet (UV) radiation over a lifetime. BCC rarely metastasizes but can cause local tissue destruction if left untreated.

The condition often appears as a pearly or waxy bump, a sore that does not heal, or a reddish patch. It may also be mistaken for a sty or chalazion, delaying diagnosis. Recognizing early signs of BCC around the eye is critical for preserving eyelid function and appearance.

Risk Factors for Periorbital BCC

Several factors increase the risk of developing BCC near the eye:

• Chronic sun exposure (UV radiation) without adequate eye protection
• Fair skin, light hair, and light eye color
• Age over 50 years
• Personal or family history of skin cancer
• Immunosuppression (e.g., organ transplant)
• Exposure to arsenic or radiation therapy

Symptoms and Signs of Eyelid BCC

The appearance of BCC beneath the eye can vary, but common features include:

• A shiny, pearly nodule with telangiectasias (small visible blood vessels)
• An open sore that bleeds, crusts, or fails to heal
• A flat, scaly reddish patch with ill-defined borders
• A white, waxy scar-like area
• Loss of eyelashes in the affected area
• Eversion (turning outward) of the eyelid if the lesion is on the lid margin

Because BCC near the eye can infiltrate deeper tissues, it may cause secondary symptoms such as tearing, pain, or a foreign body sensation. Any persistent change in the eyelid skin warrants evaluation by a dermatologist or ophthalmologist.

Diagnosis of Basal Cell Carcinoma on the Eyelid

Diagnosis begins with a thorough clinical examination. If a lesion suspicious for eyelid BCC is identified, a biopsy is performed. Usually a shave biopsy or a punch biopsy is done under local anesthesia. The tissue is sent for histopathological examination to confirm BCC and determine the subtype (e.g., nodular, superficial, morpheaform).

Imaging studies like ultrasound or MRI may be required if there is concern for orbital extension. For coding purposes, the specific location and laterality are recorded. The ICD-10 code for BCC of the left lower eyelid is C44.1022. Accurate coding is essential for treatment planning and insurance reimbursement.

Treatment Options for Periorbital BCC

Treatment of eyelid BCC aims to completely remove the cancer while preserving eyelid function and aesthetics. Options include:

• Mohs micrographic surgery – The gold standard for periorbital BCC because it offers the highest cure rate and maximal tissue conservation.
• Surgical excision with standard margins, followed by closure or reconstruction.
• Curettage and electrodesiccation for small, superficial BCCs (less common on eyelids).
• Radiation therapy for patients who cannot undergo surgery.
• Topical medications (imiquimod, 5-fluorouracil) for very superficial BCCs, but careful monitoring needed.
• Photodynamic therapy in selected cases.

Reconstructive surgery may involve flaps or grafts to restore eyelid integrity. Post-treatment surveillance is necessary due to the risk of recurrence.

ICD-10 Coding for Eyelid BCC

Proper documentation of BCC of the left lower eyelid ICD-10 is crucial. The ICD-10-CM code for basal cell carcinoma of the left lower eyelid, including canthus, is C44.1022. For the right lower eyelid, use C44.1012. For unspecified lower eyelid, C44.1092. Codes vary by laterality and specific site (eyelid, canthus, etc.). Accurate coding ensures appropriate treatment and tracking of cancer statistics.

Prevention and Outlook

Preventing BCC under the eye involves sun protection: wearing a wide-brimmed hat, UV-blocking sunglasses, and applying sunscreen to the eyelids (using mineral-based products to avoid irritation). Regular self-exams and annual dermatology check-ups are recommended, especially for those with risk factors.

The prognosis for eyelid BCC is excellent if detected early and treated adequately. Recurrence rates are low with Mohs surgery. However, advanced cases may require more extensive surgery and have higher morbidity. Awareness of the signs of periocular BCC is the first step to successful management.

In conclusion, BCC near the eye is a common but treatable skin cancer. By understanding its presentation, risk factors, and treatment options, patients and healthcare providers can work together to achieve the best outcomes. Always consult a specialist for any suspicious lesion on or around the eyelids.